NCT07570680Recruiting
Hemorrhage Stroke Decision Making Model Based Deep Learning (BrainHemoAI System)
Construction of an Integrated Intelligent Model for Spontaneous Intracerebral Hemorrhage Based on Deep Learning
Source: ClinicalTrials.gov · Last updated 6 May 2026
Brief summary (registry, in English)
Although hemorrhagic stroke also has the characteristics of high mortality and disability rates, and constitutes a major public health problem worldwide, there is a relative lack of in-depth research teams for hemorrhagic stroke in China. The current preoperative imaging evaluation of spontaneous cerebral hemorrhage is still limited to the traditional Tada formula, and there are subjective differences in diagnosis among different doctors, making it difficult to achieve homogenization in clinical decision-making. Hemorrhagic stroke is a common and frequently occurring disease in Jiangxi Province. Therefore, establishing a new diagnosis and treatment system focused on hemorrhagic stroke can not only fill the research gap in this field in China, improve the accuracy and homogeneity of hemorrhagic stroke diagnosis and treatment, but also promote related research progress to reduce the mortality and disability rates of this disease and improve the clinical prognosis of patients.
- Status (registry)
- Recruiting
- Study type
- Observational
- Enrollment
- 7100 (estimated)
- First submitted
- 29 Apr 2026
- Start date
- 1 Sept 2022
- Primary completion date
- 1 Aug 2026
- Lead sponsor
- Second Affiliated Hospital of Nanchang University
- Diseases
- Stroke
- NCT number
- NCT07570680
What you commit to
- Study type: Observational
- Planned participants: 7100
- From 1 Sept 2022 to the primary completion date, 1 Aug 2026
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Had undergone surgical treatment in another hospital before admission;
Other illness
- Had severe heart, liver, or kidney dysfunction or other life-threatening systemic diseases;
Other
- Was in a state of shock upon admission;
- Died during hospitalization;
- Had an expected lifespan of less than six months or was unable to complete the study follow-up for other reasons.
Who the study is looking for
- Age \>= 8 years old;
- Patients diagnosed with spontaneous hemorrhagic stroke based on medical history and auxiliary examinations;
- Received non-contrast computed tomography (NCCT) in the outpatient or emergency department;
- Treated in accordance with standard clinical guidelines during hospitalization;
- Have complete clinical data.
Age in the registry: 8 years to - · Sex: All · Accepts healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| The Second Affiliated Hospital of Nanchang University Coordinator of this site? Confirm its status | Nanchang | China | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.